RDY Latest Press Releases

-- September 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY PRNewswire 6:39 PM

-- September 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY Globe Newswire 8:54 PM

-- September 17, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY PRNewswire 10:02 AM

-- September 8, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY Globe Newswire 5:42 PM

-- August 27, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY PRNewswire 4:16 PM

-- August 25, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY Globe Newswire 6:25 PM

-- August 20, 2026 --

Securities Fraud Investigation Into Dr. Reddy's Laboratories (RDY) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Business Wire 11:00 AM

Dr. Reddy's Laboratories (RDY) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Business Wire 9:00 AM

-- August 19, 2026 --

Securities Fraud Investigation Into Dr. Reddy's Laboratories (RDY) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz Business Wire 6:17 PM

-- August 13, 2026 --

RDY SHAREHOLDER ALERT: Dr. Reddy's Laboratories Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations Business Wire 8:00 PM

-- August 5, 2026 --

DR. REDDY'S LABORATORIES INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud Globe Newswire 8:00 PM

-- August 4, 2026 --

Dr. Reddy's Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion, in the United States Business Wire 1:39 AM

-- July 31, 2026 --

Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky PRNewswire 10:07 AM

-- July 29, 2026 --

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Dr. Reddy's Laboratories (RDY) Globe Newswire 10:07 AM

-- July 28, 2026 --

RDY Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Dr. Reddy's Laboratories (RDY) Business Wire 10:07 AM

-- July 27, 2026 --

RDY SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Dr. Reddy's Laboratories PRNewswire 10:07 AM

-- July 24, 2026 --

Dr. Reddy's Laboratories Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Dr. Reddy's Laboratories (RDY) PRNewswire 5:06 PM

-- June 26, 2026 --

Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F Business Wire 11:10 AM

-- June 13, 2026 --

Dr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif, in the United States Business Wire 6:22 AM

-- May 29, 2026 --

NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY PRNewswire 8:55 AM

Market Data Delayed 15 Minutes